Terms: = Leukemia AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
240 results:
1. [Update on the Diagnosis and Stratification of Patients with Acute Myeloid leukemia: An Urgent National Need].
Jerez J; Briones JL; Buscaglia F; Torres C; Hidalgo S; Guerra MC; Goldschmidt V; Gazitúa R
Rev Med Chil; 2023 May; 151(5):628-638. PubMed ID: 38687545
[TBL] [Abstract] [Full Text] [Related]
2. A chest CT-based nomogram for predicting survival in acute myeloid leukemia.
Yi X; Zhan H; Lyu J; Du J; Dai M; Zhao M; Zhang Y; Zhou C; Xu X; Fan Y; Li L; Dong B; Jiang X; Xiao Z; Zhou J; Zhao M; Zhang J; Fu Y; Chen T; Xu Y; Tian J; Liu Q; Zeng H
BMC Cancer; 2024 Apr; 24(1):458. PubMed ID: 38609917
[TBL] [Abstract] [Full Text] [Related]
3. Validation of the 2022 European leukemiaNet risk stratification for acute myeloid leukemia.
Song GY; Kim HJ; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Kim MY; Cheong JW; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Choi CK; Kim HJ; Ahn JS; Kim DDH
Sci Rep; 2024 Apr; 14(1):8517. PubMed ID: 38609396
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
Luo L; Jiao Y; Li Y; Yang P; Gao J; Huang S; Huang W; Wang J; Dong F; Ke X; Zou D; Gao C; Jing H
Ann Hematol; 2024 Jun; 103(6):2073-2087. PubMed ID: 38581546
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
[TBL] [Abstract] [Full Text] [Related]
6. [Characteristics and prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic leukemia/Lymphoma from Multicenter].
Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
[TBL] [Abstract] [Full Text] [Related]
7. TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database.
Pan X; Chang Y; Ruan G; Zhou S; Jiang H; Jiang Q; Huang X; Zhao XS
Clin Exp Med; 2024 Feb; 24(1):35. PubMed ID: 38349460
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid leukemia Using Fluorescence in Situ Hybridization.
Zhang Z; Sun C; Cai L; Chen Y; Zhou X; Chen S; Feng X; Yang X; Li Q; Liu L; Zhou H; Li B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345995
[TBL] [Abstract] [Full Text] [Related]
9. Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis.
Cui J; Zhao M; Liu W; Hong M; Qian S; Sun Q
Ann Hematol; 2024 Mar; 103(3):771-780. PubMed ID: 38294533
[TBL] [Abstract] [Full Text] [Related]
10. Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Nabergoj M; Eikema DJ; Koster L; Platzbecker U; Sockel K; Finke J; Kröger N; Forcade E; Nagler A; Eder M; Tischer J; Broers AEC; Kuball J; Wilson KMO; Hunault-Berger M; Collin M; Russo D; Corral LL; Helbig G; Mussetti A; Scheid C; Gurnari C; Raj K; Drozd-Sokolowska J; Yakoub-Agha I; Robin M; McLornan DP
Bone Marrow Transplant; 2024 Mar; 59(3):395-402. PubMed ID: 38195984
[TBL] [Abstract] [Full Text] [Related]
11. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
[TBL] [Abstract] [Full Text] [Related]
12. Mutations highly specific for secondary AML are associated with poor outcomes in eln favorable risk NPM1-mutated AML.
Chan O; Al Ali N; Tashkandi H; Ellis A; Ball S; Grenet J; Hana C; Deutsch Y; Zhang L; Hussaini M; Song J; Yun S; Talati C; Kuykendall A; Padron E; Walker A; Roboz G; Desai P; Sallman D; Sweet K; Komrokji R; Lancet J
Blood Adv; 2024 Mar; 8(5):1075-1083. PubMed ID: 38170740
[TBL] [Abstract] [Full Text] [Related]
13. Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy.
Bolkun L; Pienkowski T; Sieminska J; Godzien J; Pietrowska K; Kłoczko J; Wierzbowska A; Moniuszko M; Ratajczak M; Kretowski A; Ciborowski M
Sci Rep; 2023 Dec; 13(1):21809. PubMed ID: 38071228
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world.
Zhai Y; Wang Q; Ji L; Ren H; Dong Y; Yang F; Yin Y; Liang Z; Wang Q; Liu W; Mei Y; Zhang L; Li Y
Cancer Med; 2023 Dec; 12(24):21592-21604. PubMed ID: 38062912
[TBL] [Abstract] [Full Text] [Related]
15. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract] [Full Text] [Related]
16. Albumin-to-fibrinogen ratio is an independent prognostic parameter in de novo non-M3 acute myeloid leukemia.
Ding Y; Qi X; Li Y; Sun Y; Wan J; Luo C; Huang Y; Li Q; Wu G; Zhu X; Xu S
Clin Exp Med; 2023 Dec; 23(8):4597-4608. PubMed ID: 37914966
[TBL] [Abstract] [Full Text] [Related]
17. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes.
Zhang F; Du H; Hu C; Song Y
Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study.
Sakuma T; Fujisawa S; Tanaka M; Hagihara M; Fujita H; Fujimaki K; Katsuki K; Akimoto M; Tanaka M; Matsumura A; Teshigawara H; Suzuki T; Teranaka H; Nakajima Y; Miyazaki T; Tachibana T; Matsumoto K; Sakai R; Kanamori H; Nakajima H
Hematol Oncol; 2024 Jan; 42(1):e3228. PubMed ID: 37731313
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of European leukemiaNet 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia.
Park S; Kim TY; Cho BS; Kwag D; Lee JM; Kim M; Kim Y; Koo J; Raman A; Kim TK; Kim HJ
Haematologica; 2024 Apr; 109(4):1095-1106. PubMed ID: 37706344
[TBL] [Abstract] [Full Text] [Related]
20. Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemia.
La J; Lee MH; Brophy MT; Do NV; Driver JA; Tuck DP; Fillmore NR; Dumontier C
Leuk Lymphoma; 2023 Dec; 64(13):2081-2090. PubMed ID: 37671705
[TBL] [Abstract] [Full Text] [Related]
[Next]